|Articles|February 16, 2016

CDC Evidence Points to Possible Zika-Associated Miscarriages

New research has tied the Zika virus to miscarriages in Brazil.

New research has tied the Zika virus to miscarriages in Brazil.

There is strong evidence linking Zika with microcephaly — a condition where an infant is born with a smaller-than-normal brain. Now the Centers for Disease Control and Prevention (CDC) alerted that the virus may also be the culprit of multiple miscarriages and newborn deaths in Brazil.

“Since November 2015, CDC has been developing assays for Zika virus testing in formalin-fixed paraffin embedded (FFPE) tissue samples,” the report said.

Four FFPE tissue samples were collected in December 2015 for this research: two from miscarriages and the other two from newborns with microcephaly who died within 20 hours of birth.

The two miscarriages involved fetal losses at 11 and 13 weeks. Both products of conception and placenta tissue from one miscarriage were examined. Testing ruled out herpes simplex, the human immunodeficiency virus (HIV), toxoplasmosis, rubella, and cytomegalovirus as possible causes. Placental tissue analysis was done in one of the samples.

The two newborns were born at full-term (36 and 38 weeks) with microcephaly. The researchers analyzed brain and other autopsy tissues from both newborns. One of the placentas was assessed as well. The Zika virus was present in the brains of both newborns.

All four of the mothers stated that they had clinical symptoms that are consistent with Zika, such as fever and rash, during the first trimester of their pregnancies. However, the mothers did not have these symptoms at the time of delivery or miscarriage. Results came back negative for the dengue virus in all cases. Notably, the mothers were not tested for Zika.

“Genetic sequence analysis showed that the virus in the four cases was the same as the Zika virus strain currently circulating in Brazil,” another CDC statement confirmed.

It is too soon to assume a causal relationship between the Zika virus and the miscarriages and newborn deaths. Autopsies and placental tissues are needed from additional cases in order to verify the Zika-gestational outcomes relationship.


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.